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Introduction
Pituitary secretion of follicle-stimulating hormone (FSH)
and luteinizing hormone (LH) is regulated by feedback
of ovarian hormones. Estradiol enhances LH and inhibits
FSH secretion; inhibin A and inhibin B decrease FSH
synthesis and release [1]. Inhibins are heterodimeric
glycoproteins, belonging to the transforming factor-B
growth family and are produced by granulosa cells of
the ovarian follicles [2]. Inhibin A and inhibin B have
an equipotent capacity to inhibit FSH secretion from
pituitary cells [3]. Ovarian granulosa cell tumors (GCTs)
arise from the sex cord stromal cells of the ovary and
account for 2–3% of all ovarian cancers [4]. GCTs have
two distinct subtypes, the adult and the juvenile type,
based on histopathologic and clinical features [2].
Lappohn et al reported that patients with a GCT have
high serum inhibin levels, so the GCT produces inhibin
[5]. Other studies have confirmed that inhibin B almost
always increases in patients with a GCT [6]. Initially,
immunoassays of inhibins could not distinguish between
inhibin A and B. With the development of specific
immunoassays, these forms can be recognized sepa-
rately [7]. In patients with a GCT, serum inhibin A and
B concentrations were elevated by 67% and 89%, respec-
tively [2]. Hypothalamic amenorrhea is characterized
by amenorrhea, low or low-normal levels of FSH, LH
and estradiol, and normal levels of prolactin [1]. In the
reproductive years, low levels of FSH, caused by an
inhibin-producing GCT, can lead to amenorrhea through
a central mechanism. Moreover, it can be misdiagnosed
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as hypothalamic amenorrhea. We report the case of 
a woman with an inhibin A- and inhibin B-producing
GCT who presented with secondary amenorrhea, low
levels of FSH and LH, and normal prolactin level that
resembled hypothalamic amenorrhea.
Case Report
A woman aged 26 was referred to the infertility clinic
of Doctor Shariati Hospital with 3 years’ primary infer-
tility since her marriage. She had a history of second-
ary amenorrhea over the previous 4 years. Withdrawal
bleeding was induced with medroxyprogesterone ace-
tate. Progression of puberty was normal. Menarche
had occurred at 13 years, with regular menses until 
4 years previously. Her weight and height were 65 kg 
and 160 cm, respectively. There was no evidence of 
hirsutism. Laboratory studies showed FSH 0.1 U/L, 
LH 1.4 U/L, estradiol 100 pg/mL, testosterone 0.4 ng/
mL (normal range, 0.1–1.0 ng/mL), free testosterone
2.3 pg/mL (normal range, 0.04–4.4 pg/mL), prolactin
16.9 ng/mL (normal range, 3.0–33 ng/mL), thyroid
stimulating hormone 2.2 mIU/L (normal range, 0.2–
4.9 mIU/L), dehydroepiandrosterone sulfate 2.1 μg/mL
(normal range, 0.4–3.1 μg/mL). She was referred as 
a case of hypothalamic amenorrhea, with low levels 
of FSH and LH, normal prolactin level and secondary
amenorrhea. On pelvic examination, we found a mo-
bile, non-tender, well-defined mass. Abdominal ultra-
sonography in the early follicular phase revealed a
heterogeneous solid cystic mass in the right adnexa
measuring 56 × 41 mm, and the endometrial thickness
was 6 mm. Color-flow Doppler imaging of the ovary
revealed a low-resistance vessel that is consistent with
neovascularization in malignancy (resistance index, 0.45;
pulsatility index, 0.75). We suspected malignancy and
checked tumor markers that were: α-fetoprotein 1.7 U/
mL (normal range, ≤7 U/mL), carcinoembryonic antigen
0.6 ng/mL (normal range, < 4 ng/mL), β-human chori-
onic gonadotropin 0 IU/L, CA-125 20.5 U/mL (nor-
mal range, < 35 U/mL), lactate dehydrogenase 311 U/
L (normal range, 225–500 U/L), inhibin A 255 ng/mL
(normal range, 4–150 ng/mL), inhibin B 1,124 ng/mL
(normal range, 15–200 ng/mL). Inhibin A and B were
measured using specific two-site enzyme immunoas-
says (Serotec, Oxford, UK). The patient underwent an
exploratory laparotomy. There was a mobile encapsu-
lated right ovarian mass, measuring 6 × 5 cm. The left
tube and ovary were normal, there was no sign of spread
to other pelvic organs and there was no significant
ascites. A frozen section of resected tumor indicated a
GCT, so we performed a right salpingo-oophorectomy,
peritoneal washing, partial omentectomy, and pelvic
and para-aortic lymph node sampling. Pathologic exam-
ination confirmed an adult GCT confined to the right
ovary with no lymphovascular invasion. The fallopian
tube, omentum, peritoneum and lymph nodes were
free from the tumor (stage Ia). The neoplastic cells
showed a classic adult GCT with coffee-bean appear-
ance of tumor cell nuclei. There were both well and
moderately differentiated areas, replete with microfol-
licular and macrofollicular patterns with many Call-
Exner bodies. No poorly differentiated area, unusual
mitotic figures or necrosis was observed (Figures 1 and
2). Eighteen days after surgery, she had spontaneous
menstruation. An LH surge-detecting kit confirmed
ovulation. At day 3 of the first menstruation, the
serum levels of FSH, LH and estradiol were 6.4 U/L,
5.3 U/L and 46 pg/mL, respectively. Postoperative lev-
els of inhibin B and inhibin A were 105 ng/mL and
64 ng/mL, respectively.
Figure 1. Microscopic features of the granulosa cell tumor
show neoplastic cells with Call-Exner bodies (arrow) (hema-
toxylin and eosin, 100×).
Figure 2. Microscopic features of the granulosa cell tumor
show nuclear grooves (coffee-bean appearance) of the neo-
plastic cells (arrow) (hematoxylin and eosin, 400×).
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Discussion
Hypothalamic amenorrhea is characterized by amenor-
rhea, low or low-normal levels of FSH, LH and estradiol,
and a normal level of prolactin. This diagnosis repre-
sents one of the most common forms of anovulation
and can be defined only after exclusion of pituitary and
ovarian abnormalities [1]. Functional hypothalamic
amenorrhea is often due to psychogenic stress, weight
changes, undernutrition, and excessive exercise. Infre-
quently, hypothalamic dysfunction occurs before men-
arche and presents as primary amenorrhea [8]. A GCT
secretes inhibin A and B, which inhibit FSH release
from the pituitary leading to amenorrhea with low lev-
els of FSH. Thus in premenopausal women, who pres-
ent with hypothalamic amenorrhea, it is necessary to
rule out the possibility of an ovarian tumor. Lappohn
et al [5] reported three women with secondary amen-
orrhea and infertility due to a GCT; in one case, both
FSH and LH levels were low, and in two cases, only
FSH levels were below the normal range. To the best of
our knowledge, this is the only case report that has
been presented so far which had a hormonal profile
similar to our patient. In our case, both FSH and LH
levels were low. Despite the low levels of FSH and LH,
estradiol levels were in the normal range, because the
majority of GCTs produce estrogen. After surgery, as a
consequence of removing the tumor, estradiol levels
decreased. By definition, inhibin suppresses only basal
FSH secretion from the pituitary. However, an in vitro
study suggested that at higher concentrations, inhibin
partially suppresses basal LH release [9,10].
Kurihara et al [11] reported a patient aged 31 years
with an inhibin B-secreting GCT who presented with
secondary amenorrhea. She had normal levels of LH and
estradiol and low levels of FSH. After removal of the
tumor, the serum levels of FSH and inhibin B returned to
normal. They concluded that in premenopausal women,
secondary amenorrhea may be the initial manifesta-
tion of a GCT [11]. In a patient with a GCT, the most
common presenting symptom at menopause is post-
menopausal bleeding due to prolonged exposure to
tumor-derived estrogen. In contrast, premenopausal
women may develop irregular menses or, less often,
secondary amenorrhea [12]. Moreover, the most com-
mon sign of the tumor in women with a uterus is oligo-
amenorrhea that should be considered by clinicians [4].
Krishnan et al [13] reported a woman aged 36 years
presenting with infertility, secondary amenorrhea, and
low levels of FSH similar to isolated FSH deficiency.
They termed it a pseudo-isolated FSH deficiency due
to an inhibin B-secreting GCT leading to low levels of
FSH with normal estradiol levels [13]. Not only does
the GCT have the capacity to produce high levels of
inhibin A and B, but other ovarian tumors, such as
mucinous cyst adenocarcinoma and fibrothecoma,
also release inhibin. It was shown that in patients with
mucinous cyst adenocarcinoma, inhibin B and inhibin
A increased by 60% and 20%, respectively [14]. In
patients with ovarian fibrothecoma, inhibin A and B
increased by 71% [15].
Not all patients with GCTs have elevated levels of
inhibin A and B. It was shown that inhibin B increased
in 89% and inhibin A in 67% of patients with GCTs
(60-fold and sevenfold the normal ranges, respectively)
[2]. Therefore, inhibin B markedly increases in patients
with GCTs. Inhibin A, meanwhile, increases only slightly.
In our case, both inhibin A and inhibin B increased to
255 ng/mL and 1,124 ng/mL, respectively. Our patient
had normal puberty, regular menstruation preceding
amenorrhea, and normal body mass index. Initially, she
was diagnosed as a case of hypothalamic amenorrhea.
Ovarian tumors such as a GCT, fibrothecoma and mu-
cinous cystadenocarcinoma secrete inhibin. This results
in low levels of FSH and LH with secondary amenorrhea
similar to hypothalamic amenorrhea. It appears that
in the assessment of a patient initially diagnosed with
hypothalamic amenorrhea, it is necessary to rule out
an inhibin-producing ovarian tumor. This warrants
evaluation of both ovaries with sonography and mea-
surement of serum inhibin A and B. In addition, the
presence of low FSH levels coupled with normal levels
of estradiol in a patient with amenorrhea warrants fur-
ther evaluation of inhibin A and B. Elevated levels of
inhibins in these patients must alert us to the possible
presence of inhibin-producing ovarian tumors.
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